| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 2 | |
| #2 | WIPO (World Intellectual Property Organization) | 2 | |
| #3 | Australia | 1 | |
| #4 | Brazil | 1 | |
| #5 | Canada | 1 | |
| #6 | China | 1 | |
| #7 | EPO (European Patent Office) | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Taiwan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Measurement | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Analysing materials | |
| #3 | Peptides | |
| #4 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Yang Chang Soo | 9 |
| #2 | Song Yong Bhum | 8 |
| #3 | Park Chul O | 8 |
| #4 | Lee Ji Yeong | 6 |
| #5 | Huh Won Ki | 5 |
| #6 | Kim Eun Hee | 5 |
| #7 | Lee Mi Lim | 5 |
| #8 | Jeong Jae Yeon | 5 |
| #9 | Park Hye Ryung | 5 |
| #10 | Kim So Hui | 5 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020234698A1 | Gpcr heteromer inhibitors and uses thereof | |
| KR20200103018A | GPCR heteromer inhibitors and uses thereof |